Family · Pharmaceutical analytical standards
Perampanel
An antiepileptic approved in 2012 in Europe and the United States for focal seizures and, later, also for primary generalised tonic-clonic seizures, as add-on treatment. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It was the first antiepileptic in the class of selective non-competitive antagonists of AMPA receptors, which respond to glutamate, the brain's main excitatory neurotransmitter.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
